Our data revealed that Pbrm1 loss synergized with oncogenic Kras and heterozygous or homozygous Trp53 deletion to form poorly differentiated PDAC or undifferentiated pancreatic carcinoma with squamous subtype properties. This evidence concerns the gene KRAS and exocrine pancreatic carcinoma.